Literature DB >> 1752995

Visceral leishmaniasis in human immunodeficiency virus disease.

C Montalban.   

Abstract

Entities:  

Mesh：

Year:  1991        PMID： 1752995      PMCID： PMC496648          DOI： 10.1136/jcp.44.11.965-b

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  9 in total

Review 1.  Opportunistic protozoan infections in human immunodeficiency virus disease: review highlighting diagnostic and therapeutic aspects.

Authors:  A Curry; A J Turner; S Lucas
Journal:  J Clin Pathol       Date:  1991-03       Impact factor: 3.411

2.  Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma.

Authors:  R Badaro; E Falcoff; F S Badaro; E M Carvalho; D Pedral-Sampaio; A Barral; J S Carvalho; M Barral-Netto; M Brandely; L Silva
Journal:  N Engl J Med       Date:  1990-01-04       Impact factor: 91.245

Review 3.  Epstein-Barr virus and the elderly host.

Authors:  K E Schmader; C M van der Horst; M E Klotman
Journal:  Rev Infect Dis       Date:  1989 Jan-Feb

4.  Long-term serological follow-up of patients for Epstein-Barr virus after recovery from infectious mononucleosis.

Authors:  C A Horwitz; W Henle; G Henle; H Rudnick; E Latts
Journal:  J Infect Dis       Date:  1985-06       Impact factor: 5.226

5.  Visceral leishmaniasis (kala-azar) as an opportunistic infection in patients infected with the human immunodeficiency virus in Spain.

Authors:  C Montalban; R Martinez-Fernandez; J L Calleja; J D Garcia-Diaz; R Rubio; F Dronda; S Moreno; M Yebra; C Barros; J Cobo
Journal:  Rev Infect Dis       Date:  1989 Jul-Aug

6.  A cluster of patients with a chronic mononucleosis-like syndrome. Is Epstein-Barr virus the cause?

Authors:  G P Holmes; J E Kaplan; J A Stewart; B Hunt; P F Pinsky; L B Schonberger
Journal:  JAMA       Date:  1987-05-01       Impact factor: 56.272

7.  Corticosteroid therapy in Epstein-Barr virus infection. Effect on lymphocyte class, subset, and response to early antigen.

Authors:  A Brandfonbrener; A Epstein; S Wu; J Phair
Journal:  Arch Intern Med       Date:  1986-02

8.  Visceral leishmaniasis in patients infected with human immunodeficiency virus. Co-operative Group for the Study of Leishmaniasis in AIDS.

Authors:  C Montalban; J L Calleja; A Erice; F Laguna; B Clotet; D Podzamczer; J Cobo; J Mallolas; M Yebra; A Gallego
Journal:  J Infect       Date:  1990-11       Impact factor: 6.072

9.  Visceral leishmaniasis in patients infected with human immunodeficiency virus (HIV).

Authors:  J Berenguer; S Moreno; E Cercenado; J C Bernaldo de Quirós; A García de la Fuente; E Bouza
Journal:  Ann Intern Med       Date:  1989-07-15       Impact factor: 25.391
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.